Indicated for: cancer
Route of administration: intravesical
Substance: mitomycin (antineoplastic agent)
ATC: L01DC03 (Antineoplastic and immunomodulating agents | Cytotoxic antibiotics and related substances | Other cytotoxic antibiotics)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Mitomycin is a chemotherapy drug used for the treatment of certain types of cancer, including gastric cancer, pancreatic cancer, and bladder cancer. It acts as an alkylating agent, interfering with DNA synthesis in cancer cells and inhibiting their division.
The medication is administered intravenously or intravesically, depending on the type and location of the cancer. It is effective in reducing tumor size and slowing disease progression.
Side effects may include nausea, vomiting, bone marrow suppression, increased risk of infections, and, in rare cases, pulmonary or renal toxicity. Close monitoring is essential during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Mitomycin. This medication must be administered under the supervision of an oncology specialist.